Jonathan Birchall

Insider Reports History

Location
Malvern, PA
Signature
/s/ John P. Sharp, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Birchall:

Company Role Class Num Shares Value Price $ Report Date Ownership
PhaseBio Pharmaceuticals Inc Chief Commercial Officer Common Stock 20,000 20 May 2022 Direct

Insider Reports Filed by Jonathan Birchall

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PHASQ PhaseBio Pharmaceuticals Inc 20 May 2022 1 +$13,626 4 Chief Commercial Officer 24 May 2022, 17:13
PHASQ PhaseBio Pharmaceuticals Inc 24 Feb 2022 2 $0 4 Chief Commercial Officer 28 Feb 2022, 18:25
PHASQ PhaseBio Pharmaceuticals Inc 08 Nov 2021 1 +$842,500 4 Chief Commercial Officer 09 Nov 2021, 19:46
PHASQ PhaseBio Pharmaceuticals Inc 08 Nov 2021 0 $0 3 Chief Commercial Officer 09 Nov 2021, 19:45